DSpace logo

Please use this identifier to cite or link to this item: http://142.54.178.187:9060/xmlui/handle/123456789/1400
Full metadata record
DC FieldValueLanguage
dc.date.accessioned2019-11-15T10:04:22Z-
dc.date.available2019-11-15T10:04:22Z-
dc.date.issued2009-08-11-
dc.identifier.issn6 886-
dc.identifier.urihttp://142.54.178.187:9060/xmlui/handle/123456789/1400-
dc.description.abstract5-aminolevulanic acid (ALA), belonging among the promising second generation of sensitizers, was evaluated as an inducer of photodamage on HeLa (human cervical adenocarcinoma) cell line. A diode laser (635 nm) was used as a source for initiation of the photodynamic effect. We studied the influence of different incubation times, various concentrations of sensitizer, different irradiation doses and various combinations of sensitizer and light doses on the photodamage of HeLa cells. Viability of cells was determined by means of neutral red assay. The quantitative cellular uptake of ALA sensitizer was done by spectrophotometric measurements. No prominent cytotoxic or phototoxic effects on HeLa were observed due to sensitizer or light doses when studied independently of each other. However phototoxicity evoked by laser irradiated sensitizer was detected in HeLa cell line.en_US
dc.language.isoen_USen_US
dc.publisherInstitute of Physics (IOP)en_US
dc.subjectNatural Scienceen_US
dc.subjectaminolevulinic aciden_US
dc.subjectphotodynamic therapyen_US
dc.subjectapoptosisen_US
dc.subjecthuman cervicalen_US
dc.subjectHeLa cell lineen_US
dc.titleAstro Ltd. logo Astro Ltd. logo In vitro study of 5-aminolevulinic acid-based photodynamic therapy for apoptosis in human cervical HeLa cell lineen_US
dc.typeArticleen_US
Appears in Collections:Journals

Files in This Item:
File Description SizeFormat 
pdf.htm132 BHTMLView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.